Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

Go back to Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
(NASDAQ: VVOS) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High
Open $0.17    52 Week Low
Day High $0.17    P/E N/A 
Day Low $0.16    EPS
Volume 467,538       

(NASDAQ: VVOS) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High
Open $0.17    52 Week Low
Day High $0.17    P/E N/A 
Day Low $0.16    EPS
Volume 467,538